Mammary
carcinoma induced in male Sprague-Dawley rats by multiple intragastric intubations of 7,12-dimethylbenz-(a)anthracene showed ovary-independent growth but contained
estrogen receptors (ER) and
progesterone receptors (Yoshida, Yoshida. Fukunishi, Sato, Okamoto, and Matsumoto,
Cancer Res., 42: 2434-2439, 1982). Transplantable
carcinoma (MT6) was obtained from dimethylbenz(a)
anthracene-induced mammary
carcinoma and then maintained in male rats. MT6
tumors with ER grew equally well in males, females, gonadectomized males, males given
injections of bromocryptine (1 mg/day) or
lisuride hydrogen maleate (50 micrograms/day), and gonadectomized males receiving smaller doses of
17 beta-estradiol (1 to 100 micrograms/2 days). However, the growth of MT6 was inhibited markedly by injection of a very large amount of
17 beta-estradiol (1 mg/2 days). Although transplanted MT6
tumors were
ductal carcinoma with cribriform pattern with ER,
tumors recurring after injection with 1 mg
17 beta-estradiol were found to be
spindle cell carcinoma without ER, which could grow equally well in recipients treated with or without 1 mg
17 beta-estradiol. These observations suggest that the growth of ovary-independent MT6
tumors with ER and
progesterone receptors is inhibited only by pharmacological doses of
estrogens and that the loss of growth-inhibiting effect of pharmacological doses of
estrogen of MT6
tumors occurs during high-dose
estrogen treatment.